Cargando…

Glycosylation-Engineered Platelet Membrane-Coated Interleukin 10 Nanoparticles for Targeted Inhibition of Vascular Restenosis

PURPOSE: The purpose of this study was to improve the immune compatibility and targeting abilities of IL10 nanoparticles coated with platelet membrane (IL10-PNPs) by glycosylation engineering in order to effectively reduce restenosis after vascular injury. MATERIALS AND METHODS: In this study, we re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Fengshi, Rong, Zhihua, Chen, Tianqi, Wang, Peng, Di, Xiao, Ni, Leng, Liu, Changwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492561/ https://www.ncbi.nlm.nih.gov/pubmed/37693888 http://dx.doi.org/10.2147/IJN.S423186

Ejemplares similares

Vascular restenosis reduction with platelet membrane coated nanoparticle directed M2 macrophage polarization
por: Li, Fengshi, et al.
Publicado: (2022)

Ant-Neointimal Formation Effects of SLC6A6 in Preventing Vascular Smooth Muscle Cell Proliferation and Migration via Wnt/β-Catenin Signaling
por: Rong, Zhihua, et al.
Publicado: (2023)

A Potential Target for Diabetic Vascular Damage: High Glucose-Induced Monocyte Extracellular Vesicles Impair Endothelial Cells by Delivering miR-142-5p
por: Zhang, Rui, et al.
Publicado: (2022)

Inhibition of tiRNA-Gly-GCC ameliorates neointimal formation via CBX3-mediated VSMCs phenotypic switching
por: Rong, Zhihua, et al.
Publicado: (2023)

Diabetes mellitus and adverse outcomes after carotid endarterectomy: A systematic review and meta-analysis
por: Li, Fengshi, et al.
Publicado: (2023)

Coated stents to prevent restenosis in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2005)

What Is the Future of Drug-Coated Balloons for In-Stent Restenosis?
por: Chen, Yun-Dai, et al.
Publicado: (2022)

Drug-coated balloons for the treatment of stent edge restenosis
por: Nagasaka, Takashi, et al.
Publicado: (2023)

ON VASCULAR STENOSIS, RESTENOSIS AND MANNOSE BINDING LECTIN
por: KAHLOW, Barbara Stadler, et al.
Publicado: (2016)

Noncoding RNAs in Vascular Cell Biology and Restenosis
por: Efovi, Denis, et al.
Publicado: (2022)

Drug-coated balloon in superficial femoral artery in-stent restenosis
por: Gerardi, Donato, et al.
Publicado: (2018)

Restenosis After Percutaneous Angioplasty: The Role of Vascular Inflammation
por: Schillinger, Martin, et al.
Publicado: (2005)

The Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model
por: Bae, In-Ho, et al.
Publicado: (2017)

Platelets and Defective N-Glycosylation
por: Mammadova-Bach, Elmina, et al.
Publicado: (2020)

Platelets in In-stent Restenosis: From Fundamental Role to Possible Prognostic Application
por: Haybar, Habib, et al.
Publicado: (2020)

Nitric Oxide-Producing Cardiovascular Stent Coatings for Prevention of Thrombosis and Restenosis
por: Rao, Jingdong, et al.
Publicado: (2020)

Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis
por: Xue, Weihao, et al.
Publicado: (2022)

Bioresorbable Vascular Scaffold Use in a Case of In-stent Restenosis
por: Cadrin-Tourigny, Julia, et al.
Publicado: (2014)

Biological effect on drug distribution and vascular healing via paclitaxel‐coated balloon technology in drug eluting stent restenosis swine model
por: Li, Yan, et al.
Publicado: (2015)

Effect of Stents Coated with Artemisinin or Dihydroartemisinin in a Porcine Coronary Restenosis Model
por: Jang, Suyoung, et al.
Publicado: (2017)

Long-term efficacy of drug-coated balloon for renal artery in-stent restenosis
por: Elwany, Mostafa, et al.
Publicado: (2018)

Outcomes of Dissection Angles as Predictor of Restenosis after Drug-Coated Balloon Treatment
por: Kozuki, Amane, et al.
Publicado: (2021)

Establishment of an Animal Model of Vascular Restenosis with Bilateral Carotid Artery Grafting
por: Li, Ruixiong, et al.
Publicado: (2014)

Fully bioresorption of an Absorb bioresorbable vascular scaffold after scaffold restenosis
por: Goncalves-Ramírez, Luis R., et al.
Publicado: (2019)

Distinctive effects of CD34- and CD133-specific antibody-coated stents on re-endothelialization and in-stent restenosis at the early phase of vascular injury
por: Wu, Xue, et al.
Publicado: (2015)

Restenosis of a drug eluting stent on the previous bioresorbable vascular scaffold successfully treated with a drug-coated balloon: A case report
por: Jang, Hyun Gyung, et al.
Publicado: (2021)

Coronary restenosis
Publicado: (1993)

Restenosis and Therapy
por: Denes, Laszlo, et al.
Publicado: (2012)

Diabetes and restenosis
por: Wilson, Scott, et al.
Publicado: (2022)

Role of Glycosylation in Vascular Calcification
por: Masbuchin, Ainun Nizar, et al.
Publicado: (2021)

Combination of polyglycerol sebacate coated with collagen for vascular engineering
por: Nazary Abrbekoh, Fateme, et al.
Publicado: (2022)

Anti-inflammatory Effect of Abciximab-Coated Stent in a Porcine Coronary Restenosis Model
por: Hong, Young Joon, et al.
Publicado: (2007)

Feasibility and Safety of Paclitaxel-Coated Balloon Angioplasty for the Treatment of Intracranial Symptomatic In-Stent Restenosis
por: Xu, Haowen, et al.
Publicado: (2020)

Drug-Coated Balloon for the Treatment of Femoropopliteal Tosaka Class III In-stent Restenosis Lesions
por: Zhang, Bihui, et al.
Publicado: (2021)

High levels of HB-EGF and interleukin-18 are associated with a high risk of in-stent restenosis
por: Jiang, Hua, et al.
Publicado: (2016)

Periadventitial Application of Rapamycin-Loaded Nanoparticles Produces Sustained Inhibition of Vascular Restenosis
por: Shi, Xudong, et al.
Publicado: (2014)

Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation
por: McDonald, Robert A., et al.
Publicado: (2015)

Ending Restenosis: Inhibition of Vascular Smooth Muscle Cell Proliferation by cAMP
por: Smith, Sarah A., et al.
Publicado: (2019)

Apolipoprotein A-I Reduces In-Stent Restenosis and Platelet Activation and Alters Neointimal Cellular Phenotype
por: Vanags, Laura Z., et al.
Publicado: (2018)

miR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis
por: Wang, Jing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j73lh6lo0hj3of5hg6krh8mtj6